Leading science, pioneering therapies

CRM Publications

Found 5 results
Filters: Keyword is Cyclin-Dependent Kinase Inhibitor p21  [Clear All Filters]
2013
M Marqués-Torrejón Á, Porlan E, Banito A, Gómez-Ibarlucea E, Lopez-Contreras AJ, Fernández-Capetillo O, Vidal A, Gil J, Torres J, Fariñas I.  2013.  Cyclin-dependent kinase inhibitor p21 controls adult neural stem cell expansion by regulating Sox2 gene expression.Cell Stem Cell. 12(1):88-100.
Porlan E, Morante-Redolat JManuel, M Marqués-Torrejón Á, Andreu-Agulló C, Carneiro C, Gómez-Ibarlucea E, Soto A, Vidal A, Ferrón SR, Fariñas I.  2013.  Transcriptional repression of Bmp2 by p21(Waf1/Cip1) links quiescence to neural stem cell maintenance.Nat Neurosci. 16(11):1567-75.
2012
Balikova A, Jääger K, Viil J, Maimets T, Kadaja-Saarepuu L.  2012.  Leukocyte marker CD43 promotes cell growth in co-operation with β-catenin in non-hematopoietic cancer cells.Int J Oncol. 41(1):299-309.
2010
Zupkovitz G, Grausenburger R, Brunmeir R, Senese S, Tischler J, Jurkin J, Rembold M, Meunier D, Egger G, Lagger S et al..  2010.  The cyclin-dependent kinase inhibitor p21 is a crucial target for histone deacetylase 1 as a regulator of cellular proliferation.Mol Cell Biol. 30(5):1171-81.
2002
Lagger G, O'Carroll D, Rembold M, Khier H, Tischler J, Weitzer G, Schuettengruber B, Hauser C, Brunmeir R, Jenuwein T et al..  2002.  Essential function of histone deacetylase 1 in proliferation control and CDK inhibitor repression.EMBO J. 21(11):2672-81.